AVIR vs PCRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 29, 2026

AVIR

54.9
AI Score
VS
AVIR Wins

PCRX

52.0
AI Score

Investment Advisor Scores

AVIR

55score
Recommendation
HOLD

PCRX

52score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric AVIR PCRX Winner
Forward P/E 0 5.8893 Tie
PEG Ratio 0 -3.83 Tie
Revenue Growth 295.2% 6.5% AVIR
Earnings Growth 264.1% -47.8% AVIR
Tradestie Score 54.9/100 52.0/100 AVIR
Profit Margin 0.0% 3.0% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, AVIR is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.